Cargando…
IL-23 Blockade in Anti-TNF Refractory IBD: From Mechanisms to Clinical Reality
Increasing insights into the immunopathogenesis of inflammatory bowel diseases [IBD] have led to the advent of targeted therapies that inhibit crucial mediators of the inflammatory process, thereby widening our available therapeutic armamentarium. Anti-tumour necrosis factor [anti-TNF] agents are st...
| Autores principales: | , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Oxford University Press
2022
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9097672/ https://www.ncbi.nlm.nih.gov/pubmed/35553662 http://dx.doi.org/10.1093/ecco-jcc/jjac007 |